Abstract Esophageal cancer is a malignant tumor of the digestive system that has a high incidence in China. The traditional treatment methods include surgery, radiotherapy, and chemotherapy, but the long-term efficacy is not good and the side effects are obvious. As a traditional physical therapy, hyperthermia has no significant toxic and side effects. Studies have shown that hyperthermia can increase the sensitivity of esophageal cancer to radiotherapy and chemotherapy, and its combined use in the treatment of esophageal cancer can prolong the survival and improve the quality of life. In addition, the innovation of materials and technologies brings new breakthroughs to tumor hyperthermia.
Corresponding Authors:
Yang Daoke, Email:15903650068@163.com
Cite this article:
Yang Yongqiang,Li Xiaole,Zhang Xiangxian et al. Research progress on hyperthermia for esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2022, 31(3): 288-292.
Yang Yongqiang,Li Xiaole,Zhang Xiangxian et al. Research progress on hyperthermia for esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2022, 31(3): 288-292.
[1] 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志,2019, 41(1):19-28. DOI:10.3760/cma.j.issn.0253-3766.2019.01.008. Zheng RS, Sun KX, Zhang SW, et al. Report of cancer epidemiology in China, 2015[J]. Chin J Oncol, 2019, 41(1):19-28. DOI:10.3760/cma.j.issn.0253-3766.2019.01.008. [2] Januszewski A, Stebbing J. Hyperthermia in cancer:is it coming of age?[J]. Lancet Oncol, 2014, 15(6):565-566. DOI:10.1016/S1470-2045(14)70207-4. [3] 郑国宝,张建国. 热疗联合化疗对中晚期食管癌的疗效观察[J]. 山西医药杂志,2015,44(17):1975-1978. Zheng GB, Zhang JG. Therapeutic effect of hyperthermia combined with chemotherapy on patients with advanced esophageal carcinoma[J]. Shanxi Med J,2015,44(17):1975-1978. [4] 章岳山,郭方,唐铁钢,等. 大功率微波肿瘤热化疗多中心临床分析[J]. 科技导报,2014, 32(30):59-62. DOI:10.3981/j.issn.1000-7857.2014.30.010. Zhang YS, Guo F, Tang TG, et al. Clinical analysis of multi-center for tumor chemotherapy combined with high power microwave-hyperthermia[J]. Sci Technol Rev,2014,32(30):59-62. DOI:10.3981/j.issn.1000-7857.2014.30.010. [5] Nishimura S, Saeki H, Nakanoko T, et al. Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy[J]. Anticancer Res, 2015, 35(4):2299-2303. [6] Lassche G, Crezee J, Van Herpen C. Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies[J]. Crit Rev Oncol Hematol, 2019, 139:67-74. DOI:10.1016/j.critrevonc.2019.04.023. [7] 尹树山,陈刚,陶艳. 深部热疗结合放疗治疗老年晚期食管癌的疗效观察[J]. 临床医药文献电子杂志, 2019, 6(16):19-20. DOI:10.3877/j.issn.2095-8242.2019.16.013. Yin SS, Cheng G, Tao Y. Efficacy of deep hyperthermia combined with radiotherapy in the treatment of advanced esophageal cancer in the elderly[J]. Elect J Clin Med Literat,2019,6(16):19-20. DOI:10.3877/j.issn.2095-8242.2019.16.013. [8] 李征,米登海,杨克虎,等. 放疗联合热疗治疗食管癌的Meta分析[J]. 中华肿瘤防治杂志,2012, 19(9):671-675. DOI:10.16073/j.cnki.cjcpt.2012.09.013. Li Z, Mi DH, Yang KH, et al. Radiotherapy plus thermotherapy for esophageal carcinoma:a meta-analysis[J]. Chin J Cancer Prev Treat, 2012, 19(9):671-675. DOI:10.16073/j.cnki.cjcpt.2012.09.013. [9] Datta NR, Ordóñez SG, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy:recent advances and promises for the future[J]. Cancer Treat Rev, 2015, 41(9):742-753. DOI:10.1016/j.ctrv.2015.05.009. [10] Vellayappan BA, Soon YY, Ku GY, et al. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer[J]. Cochrane Database Syst Rev, 2017, 8(8):CD010511. DOI:10.1002/14651858. CD010511.pub2. [11] 任永霞,张月,杨宏耀,等. 热疗增敏新辅助放化疗治疗进展期食管癌[J]. 河南医学研究,2018, 27(4):618-621. DOI:10.3969/j.issn.1004-437X.2018.04.015. Ren YX, Zhang Y, Yang HY, et al. Hyperthermia combined with neoadjuvant chemoradiotherapy in the treatment of advanced esophageal cancer[J]. Henan Medical Research, 2018, 27(4):618-621. DOI:10.3969/j.issn.1004-437X.2018.04.015. [12] 唐志,王镇南,蔡小碧,等. 同期放化疗联合深部热疗治疗胸段食管癌的临床观察[J]. 现代肿瘤医学, 2015(11):1524-1527. DOI:10.3969/j.issn.1672-4992.2015.11.14. Tang Z, Wang ZN, Cai XB, et al. Clinical observation of concurrent radiochemotherapy combined with deep hyperthermia on thoracic esophageal carcinoma[J]. J Mod Oncol,2015(11):1524-1527. DOI:10.3969/j.issn.1672-4992.2015.11.14. [13] 牛松涛. 同期放化疗联合深部热疗治疗食管癌[J]. 肿瘤基础与临床,2016, 29(5):420-422. DOI:10.3969/j.issn.1673-5412.2016.05.015.Niu ST. Concurrent radiotherapy and chemotherapy combined with deep hyperthermia in the treatment of esophageal cancer[J]. J Basic Clin Oncol, 2016, 29(5):420-422. DOI:10.3969/j.issn.1673-5412.2016.05.015. [14] 王宝中,赵军,王彦文,等. BSD热疗联合放化疗同步治疗腹膜后淋巴结转移癌临床观察[J]. 肿瘤基础与临床, 2010, 23(5):410-412. DOI:10.3969/j.issn.1673-5412.2010.05.018. Wang BZ, Zhao J, Wang YW, et al. A clinical study of retroperitoneal lymph node metastasis cancer treated by BSD thermotherapy combined with radiotherapy and chemotherapy[J]. J Basic Clin Oncol, 2010, 23(5):410-412. DOI:10.3969/j.issn.1673-5412.2010.05.018. [15] Hu Y, Li Z, Mi DH, et al. Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer:a systematic review and meta-analysis[J]. J Clin Pharm Ther, 2017, 42(2):155-164. DOI:10.1111/jcpt.12498. [16] Xi M, Xu C, Liao Z, et al. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy[J]. Radiother Oncol, 2017, 124(2):318-324. DOI:10.1016/j.radonc.2017.06.019. [17] Hulshof MC, Van Haaren PM, Van Lanschot JJ, et al. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer[J]. Int J Hyperthermia, 2009, 25(1):79-85. DOI:10.1080/02656730802464078. [18] Nakajima M, Kato H, Sakai M, et al. Planned esophagectomy after neoadjuvant hyperthermo-chemoradiotherapy using weekly low-dose docetaxel and hyperthermia for advanced esophageal carcinomas[J]. Hepatogastroenterology, 2015, 62(140):887-891. [19] Kitamura K, Kuwano H, Watanabe M, et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma[J]. J Surg Oncol, 1995, 60(1):55-58. DOI:10.1002/jso.2930600111. [20] Hong Y, Ding ZY. PD-1 inhibitors in the advanced esophageal cancer[J]. Front Pharmacol, 2019, 10:1418. DOI:10.3389/fphar.2019.01418. [21] Hurwitz MD. Hyperthermia and immunotherapy:clinical opportunities[J]. Int J Hyperthermia, 2019, 36(Sup1):4-9. DOI:10.1080/02656736.2019.1653499. [22] Qiao G, Wang X, Zhou X, et al. Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors[J]. Int J Hyperther, 2019, 36(Sup1):74-82. DOI:10.1080/02656736.2019.16473 50. [23] Kleef R, Moss R, Szasz AM, et al. Complete clinical remission of stage ⅠV triple-negative breast cancer lung metastasis aDministering low-dose immune checkpoint blockade in combination with hyperthermia and interleukin-2[J]. Integr Cancer Ther, 2018, 17(4):1297-1303. DOI:10.1177/1534735418794867. [24] Chen Q, Hu Q, Dukhovlinova E, et al. Photothermal therapy promotes tumor infiltration and antitumor activity of CAR T cells[J]. Adv Mater, 2019, 31(23):e1900192. DOI:10.1002/adma.201900192. [25] Wang Z, Zhang F, Shao D, et al. Janus nanobullets combine photodynamic therapy and magnetic hyperthermia to potentiate synergetic anti-metastatic immunotherapy[J]. Adv Sci (Weinh), 2019, 6(22):1901690. DOI:10.1002/advs.201901690. [26] Qin Y, Sun Y, Liu Y, et al. Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC[J]. Thorac Cancer, 2016, 7(4):422-427. DOI:10.1111/1759-7714.12346. [27] Gadaleta-Caldarola G, Infusino S, Galise I, et al. Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma:a phase Ⅱ study[J]. Oncol Lett, 2014, 8(4):1783-1787. DOI:10.3892/ol.2014.2376. [28] Chang M, Hou Z, Wang M, et al. Recent advances in hyperthermia therapy-based synergistic immunotherapy[J]. Adv Mater, 2021, 33(4):e2004788. DOI:10.1002/adma.202004788. [29] Chandrasekharan P, Tay ZW, Hensley D, et al. Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment:tracers, hardware, and future medical applications[J]. Theranostics, 2020, 10(7):2965-2981. DOI:10.7150/thno.40858. [30] Cervadoro A, Cho M, Key J, et al. Synthesis of multifunctional magnetic nanoflakes for magnetic resonance imaging, hyperthermia, and targeting[J]. ACS Appl Mater Interfaces, 2014, 6(15):12939-12946. DOI:10.1021/am504270c. [31] Akiyama S, Kawasaki S, Kodera Y, et al. A new method of thermo-chemotherapy using a stent for patients with esophageal cancer[J]. Surg Today, 2006, 36(1):19-24. DOI:10.1007/s00595-005-3089-1. [32] 简超. 纳米金膜记忆合金食管支架的安全性及对食管癌的红外热疗探索[D]. 西安:中国人民解放军空军军医大学,2018.Jian C. Study on the safety and infrared thermal therapy of gold nanoshell coated esophageal stent in treatment of esophageal cancer[D]. Xi'an:Air Force Medical University,2018. [33] Lee S, Hwang G, Kim TH, et al. On-demand drug release from gold nanoturf for a thermo-and chemotherapeutic esophageal stent[J]. ACS Nano, 2018, 12(7):6756-6766. DOI:10.1021/acsnano.8b01921. [34] Aguilar LE, Tumurbaatar B, Ghavaminejad A, et al. Functionalized non-vascular nitinol stent via electropolymerized polydopamine thin film coating loaded with bortezomib adjunct to hyperthermia therapy[J]. Sci Rep, 2017, 7(1):9432. DOI:10.1038/s41598-017-08833-x. [35] Al Faruque H, Choi ES, Lee HR, et al. Targeted removal of leukemia cells from the circulating system by whole-body magnetic hyperthermia in mice[J]. Nanoscale, 2020, 12(4):2773-2786. DOI:10.1039/c9nR06730b. [36] 刘嘉毅. 支架磁感应热疗食管肿瘤的实验研究[D]. 长沙:中南大学,2011.Liu JY. Experimental study on stent-magnetic hyperthermia for esophageal cancer treatment[D]. Changsha:Central South University,2011. [37] 中日医学科技交流协会热疗专业委员会,中华医学会放疗分会热疗专业委员会. 中国肿瘤热疗临床应用指南(2017. V1.1)[J]. 中华放射肿瘤学杂志,2017,26(4):369-375. DOI:10.3760/cma.j.issn.1004-4221.2017.04.001.Sino Japan Science and Technology Association, Chinese Medical Association Radiotherapy Branch Thermotherapy Specialized Committee. Chinese application guide of clinical application of tumor hyperthermia (2017. V1.1)[J]. Chin J Radiat Oncol, 2017,26(4):369-375. DOI:10.3760/cma.j.issn.1004-4221.2017.04.001. [38] Bakker A, van der Zee J, van Tienhoven G, et al. Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity:a systematic review[J]. Int J Hyperthermia, 2019, 36(1):1024-1039. DOI:10.1080/02656736.2019.1665718. [39] Qi C, Li DJ. Thermometric analysis of intra-cavitary hyperthermia for esophageal cancer[J]. Int J Hyperther, 1999, 15(5):399-407. DOI:10.1080/026567399285585. [40] 李夏东,马胜林,吴稚冰,等. 肿瘤深部热疗智能温控系统临床效果研究[J]. 中华放射肿瘤学杂志,2016, 25(11):1244-1247. DOI:10.3760/cma.j.issn.1004-4221.2016.11.022. Li XD, Ma SL, Wu ZB, et al. Clinical effectiveness of an intelligent shell temperature control system in deep tumor hyperthermia[J]. Chin J Radiat Oncol, 2016, 25(11):1244-1247. DOI:10.3760/cma.j.issn.1004-4221.2016.11.022. [41] Dunne M, Epp-Ducharme B, Sofias AM, et al. Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies[J]. J Control Release, 2019, 308:197-208. DOI:10.1016/j.jconrel.2019.06.012.
2022, Vol. 31 
